Investment and co-development partners for a buccal drug delivery platform (TRL 5 → TRL 6)

Medical Flowers Developments is developing a buccal drug delivery platform based on medicated chewing gum, designed to bring complex botanical and non-botanical APIs to pharmaceutical standards.

The project is currently at TRL 5, with a robust galenic base and a clearly defined preclinical and clinical transition strategy. The next step (TRL 6) includes GMP manufacturing, analytical validation, CTA submission to AEMPS and execution of a Phase I clinical study (PK).

We are seeking:

• Biotech and life sciences investors

• Strategic industrial partners

• Clinical and translational partners

• Organisations interested in co-development or coinvestment

The platform is adaptable to multiple therapeutic areas. The first clinical programme is focused on medical cannabis, aligned with the evolving European and Spanish regulatory framework requiring clinical evidence.

What we offer

• Proprietary buccal delivery platform

• Defined TRL 5 → TRL 6 execution plan

• Industrial partners already involved in I+D

• Active clinical network engagement in Spain

What we are looking for

• Equity investment and/or strategic partnership

• Co-development opportunities

• Clinical and industrial collaboration

4